Resistencias a fármacos de Mycobacterium tuberculosis en la Comunidad de Castilla y León (España), 2001-2005: tercer estudio multicéntrico

The incidence of primary drug resistance in the surveyed area was low, including isoniazid, allowing new anti-tuberculosis treatment with the standardised three-drug regimen to be started. Regular surveillance of drug resistance is recommended by the TB control programme in representative patient populations to optimize treatment regimens.